Targeting LLT1 as a potential immunotherapy option for cancer patients non-responsive to existing checkpoint therapies in multiple solid tumors von Mandal, Tirtha, Gnanasegaran, Soorya, Rodrigues, Golding, Kashipathi, Shalini, Tiwari, Anurag, Dubey, Ashvini Kumar, Bhattacharjee, Sanghamitra, Manjunath, Yogendra, Krishna, Subith, Madhusudhan, M S, Ghosh, Maloy

Volltext

Hexane Fraction of Turbo brunneus Inhibits Intermediates of RANK-RANKL Signaling Pathway and Prevent Ovariectomy Induced Bone Loss von Chaugule, Sachin, Kashipathi Sureshbabu, Shalini, Dakave, Suresh, Krishna, C. Murali, Chaudhari, Pradip, Indap, Madhavi, Chiplunkar, Shubhada

Volltext

Transcriptome Signature of Vγ9Vδ2 T Cells Treated With Phosphoantigens and Notch Inhibitor Reveals Interplay Between TCR and Notch Signaling Pathways von Madhok, Ayush, Bhat, Sajad Ahmad, Philip, Chinna Susan, Sureshbabu, Shalini Kashipathi, Chiplunkar, Shubhada, Galande, Sanjeev

Volltext

719 Phase 1 clinical trial design of ZM008, a first-in-class anti LLT1 antibody is a promising therapy for multiple solid cancers von Ghosh, Maloy, Tiwari, Anurag, Dubey, Ashvini Kumar, Bhattacharjee, Sanghamitra, Manjunath, Yogendra, Kashipathi, Shalini, Krishna, Subith, Mandal, Tirtha, Gnanasegaran, Soorya, Garcia-Ribas, Ignacio

Volltext

1391 ZM008 a first in class monoclonal anti LLT1 antibody demonstrated clinical potential in multiple solid cancers von Ghosh, Maloy, Tiwari, Anurag, Dubey, Ashvini, Bhattacharjee, Sanghamitra, Manjunath, Yogendra, Kashipathi, Shalini, Subith Krishna

Volltext

Immunosuppressive role of γδ T cells in cancer: the other side of the coin von Patil, Rushikesh, Sureshbabu, Shalini Kashipathi, Chiplunkar, Shubhada V.

Volltext

Generation of islet-like cell aggregates from human non-pancreatic cancer cell lines von Kanafi, Mohammad Mahboob, Mamidi, Murali Krishna, Sureshbabu, Shalini Kashipathi, Shahani, Pradnya, Bhawna, Chandravanshi, Warrier, Sudha R., Bhonde, Ramesh

Volltext